2-Pyrimidinecarboxylic acid, 5-hydroxy- (9CI)
|
- $1110 - $1702
- Product name: 2-Pyrimidinecarboxylic acid, 5-hydroxy- (9CI)
- CAS: 345642-87-7
- MF: C5H4N2O3
- MW: 140.1
- EINECS:
- MDL Number:MFCD16619299
- Synonyms:2-Pyrimidinecarboxylic acid, 5-hydroxy- (9CI);2-Carboxy-5-pyrimidinol;5-Hydroxy-2-pyrimidinecarboxylic acid;2-Pyrimidinecarboxylic acid, 5-hydroxy-;5-hydroxypyrimidine-2-carboxylicaci;2-Pyrimidinecarboxylic acid, 5-hydroxy- (9CI) ISO 9001:2015 REACH
3 prices
Selected condition:
Brand
- AK Scientific
- Crysdot
- Matrix Scientific
Package
- 1g
- ManufacturerAK Scientific
- Product number9793AF
- Product description5-Hydroxy-2-pyrimidinecarboxylicacid
- Packaging1g
- Price$1702
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11139267
- Product description5-Hydroxypyrimidine-2-carboxylicacid 95%
- Packaging1g
- Price$1110
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number126910
- Product description5-Hydroxypyrimidine-2-carboxylicacid >95%
- Packaging1g
- Price$1224
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | 9793AF | 5-Hydroxy-2-pyrimidinecarboxylicacid | 1g | $1702 | 2021-12-16 | Buy |
| Crysdot | CD11139267 | 5-Hydroxypyrimidine-2-carboxylicacid 95% | 1g | $1110 | 2021-12-16 | Buy |
| Matrix Scientific | 126910 | 5-Hydroxypyrimidine-2-carboxylicacid >95% | 1g | $1224 | 2021-12-16 | Buy |
Properties
Boiling point :478.8±37.0 °C(Predicted)
Density :1.613
storage temp. :2-8°C
pka :3.45±0.10(Predicted)
Density :1.613
storage temp. :2-8°C
pka :3.45±0.10(Predicted)
Safety Information
| Symbol(GHS): |
|
||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | ||||||||||||||||||||||||||||||||||||||||||
| Hazard statements: |
|
||||||||||||||||||||||||||||||||||||||||||
| Precautionary statements: |
|




